2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Tuesday, June 5, 2018

4:30pm-4:42pm: Improving the Organ Donation Referral Process through Telemedicine

M. Groveman,¹ M. Perry,² I. Berman,² N. Benavides,¹ A. Friedman.¹

Concurrent Session: Quality Assurance Process Improvement • Room 2AB

4:30pm-4:42pm: Interferon-b Promotes Regulatory T Cell (Treg) Induction and Prolongs Allograft Survival

M. Fribourg,¹ M. McGinty,² A. Angeletti,² M. Demir,² S. Sealfon,¹ P. Heeger,² P. Cravedi.²

Concurrent Session: New Approaches to Target Regulatory T Cells • Room 618/619/620

4:30pm-4:42pm: Liver Transplantation for Patients with Hepatocellular Carcinoma Presenting beyond Milan Criteria: Analysis of 789 Patients from the US Multicenter HCC Transplant Consortium

V. Agopian, United States Multicenter HCC Transplant Consortium.

Concurrent Session: Liver: Hepatocellular Carcinoma and Other Malignancies • Room 6C

4:30pm-4:42pm: Medical Crowdfunding for Organ Transplant Patients

W. Durand,¹ J. Peters,¹ A. Eltorai,¹ S. Kalagara,¹ A. Osband,² A. Daniels.³

Concurrent Session: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics - 3 • Room 4C-4

4:30pm-4:42pm: Meeting OPTN Requirements for Living Kidney Donation Follow-Up: Findings from the KDOC Study

J. Rodrigue,¹ C. Sokas,¹ A. Fleishman,¹ J. Schold,² P. Morrissey,³ J. Whiting,⁴ J. Vella,⁴ L. Kayler,⁵ D. Katz,⁶ J. Jones,⁶ B. Kaplan,⁷ M. Pavlakis,¹ D. Mandelbrot.⁸

Concurrent Session: Kidney Living Donation: Programmatic Issues • Room 6B

4:30pm-4:42pm: Not All HLA Mismatches Are Equal: Determining the Relative De Novo DSA Induction Capacity of HLA Mismatches

V. Jucaud,¹ L. Rebellato,² K. Briley,² A. Maldonado,³ C. Haisch,² P. Bolin,² S. Kendrick,⁴ H. Jones,⁴ K. McLawhorn,⁴ D. Leeser,² M. Everly.¹

Concurrent Session: Kidney Donor Selection / Management Issues - 2 • Room 6E

4:30pm-4:42pm: Relationship between Mixed Chimerism and Acceptance of HLA-Matched and Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs

J. Scandling, S. Busque, R. Lowsky, J. Shizuru, K. Jensen, A. Shori, E. Engleman, E. Meyer, R. Hoppe, S. Strober.

Concurrent Session: Tolerance: Clinical Studies • Room 210

4:30pm-4:42pm: Split/Reduced Liver Grafts in Adult Liver Transplantation, No Longer a Risk for Graft Loss

K. Sasaki, D. Firl, J. McVey, G. Iuppa, M. Fujiki, T. Diago Uso, F. Aucejo, B. Eghtesad, C. Quintini, C. Miller, K. Hashimoto.

Concurrent Session: Liver: Living Donors and Partial Grafts • Room 608/609

4:30pm-4:42pm: Tacrolimus Pharmacokinetics (PK) at Low, Medium, and High Trough Levels in Patients Converted from Twice-Daily Immediate-Release Tacrolimus (TacBID) to Once-Daily Extended-Release Tacrolimus (LCPT)

P. Malvezzi,¹ S. Bunnapradist,² D. Stevens,³ M. Moten,³ A. Loh,³ S. Patel,³ L. Rostaing.¹

Concurrent Session: Kidney Immunosuppression: General Considerations - 2 • Room 6A

4:30pm-4:42pm: The Results of the PRISM (Prediction of Rejection In Sensitized Patient Blood SaMples) Trial with a Novel Bioassay

F. Vincenti, A. Schroeder, S.-C. Hseish, J. Liberto, P. Towfighi, C. Koh, T. Sigdel, M. Sarwal.

Concurrent Session: Late Breaking • Room 3AB